Understanding the pathogenic mechanisms and therapeutic effects in neurocysticercosis

Gino Castillo,Lizbeth Fustamante,Ana D. Delgado‐Kamiche,Rogger P. Camen‐Orozco,Taryn Clark,Edson Bernal,Jemima Morales‐Alvarez,Maria Ferrufino,Javier Mamani‐Palomino,Javier A. Bustos,Hector H. Garcia,Cesar M. Gavidia,Robert H. Gilman,Manuela Verastegui,Cysticercosis Working Group in Peru
DOI: https://doi.org/10.1111/bpa.13237
IF: 7.611
2024-01-13
Brain Pathology
Abstract:Grey and white matter pathological differences in neurocysticercosis. Grey matter showing severe spongy change (arrows), inflammatory infiltrate (arrowhead), and abundant axonal spheroids (arrows), while white matter showing slight spongy change (arrow), inflammatory infiltrate (arrowhead), and small varicosities (arrows). Despite being a leading cause of acquired seizures in endemic regions, the pathological mechanisms of neurocysticercosis are still poorly understood. This study aims to investigate the impact of anthelmintic treatment on neuropathological features in a rat model of neurocysticercosis. Rats were intracranially infected with Taenia solium oncospheres and treated with albendazole + praziquantel (ABZ), oxfendazole + praziquantel (OXF), or untreated placebo (UT) for 7 days. Following the last dose of treatment, brain tissues were evaluated at 24 h and 2 months. We performed neuropathological assessment for cyst damage, perilesional brain inflammation, presence of axonal spheroids, and spongy changes. Both treatments showed comparable efficacy in cyst damage and inflammation. The presence of spongy change correlated with spheroids counts and were not affected by anthelmintic treatment. Compared to white matter, gray matter showed greater spongy change (91.7% vs. 21.4%, p
pathology,neurosciences,clinical neurology
What problem does this paper attempt to address?